Congrats to Cherie Strikwerda-Brown et al on recent findings reported in JAMA Neurology of clinical significance of PET biomarker scanning for beta amyloid plaque and tau aggregates in four different independent population-based cohorts (PEVENT-AD, HABS, AIBL, and Knight ADRC).
English